Select Page

Blog

FSR Welcomes New Global Head of Clinical Engagement!

FSR Welcomes New Global Head of Clinical Engagement!

The Foundation for Sarcoidosis Research (FSR)’s team is growing to better support the needs identified by the sarcoidosis community!  FSR is pleased to announce that Diane Driscoll joined the FSR team as Global Head of Clinical Engagement effective February 1, 2022. ...
Act Now to Protect Drug Development

Act Now to Protect Drug Development

Act Now to Protect Drug Development.   As part of the budgeting process, Congress is discussing cutting back the Orphan Drug Tax Credit for pharmaceutical companies. Most of the drugs in sarcoidosis are not FDA-approved for sarcoidosis, but are repurposed from...
Translate »